A Risk Sciences International news item posted on June 22, 2021 and last updated on June 30, 2021

Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised concern about their possible association with acute hepatic failure (AHF). Data from the US FDA Adverse Event Reporting System were evaluated for signals of AHF in association with systemically administered quinolone antibiotics.

A recent study published by RSI’s Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski in the journal JGH Open: An open access journal of gastroenterology and hepatology, has shown that only ciprofloxacin displayed a marginal and significant AHF signal (PRR: 1.85 [1.21, 2.81]; EBGM: 1.54 [1.06, 1.81]); moxifloxacin, levofloxacin, and ofloxacin showed weak and nonsignificant signals.

The research team concluded that further pharmacovigilance studies are required to confirm the association between ciprofloxacin and AHF seen in the present analysis.

The paper is available by clicking here.

More RSI News

Bias Assessment in Case-Control and Cohort Studies for Hazard Identification

November 4, 2025

IARC recently published a volume on quantitative bias modelling: Bias assessment in case–control and cohort studies for hazard identification (IARC Scientific Publication No. 171). We…

Read News Item

RSI Helps Strengthen Food Safety Culture in Vietnam

October 21, 2025

In mid-October 2025, Vietnamese and Canadian experts convened in Đà Nẵng to exchange approaches for strengthening food safety through risk science. The workshop brought together…

Read News Item

Use of Probabilistic Exposure Models in the Assessment of Dietary Exposure to Chemicals 

August 26, 2025

Risk Sciences International CEO, Greg Paoli and RSI senior experts Emma Hartnett and Paul Price, have co-authored a new peer-reviewed publication highlighting the critical role…

Read News Item

Aging and cognitive decline

September 21, 2023

Working with the College of Physicians and Surgeons of Alberta, Risk Sciences International conducted a wide-ranging review of aging and cognitive decline, with specific focus on aging physicians and fitness to practice.  The publication in Aging & Mental Health documents domains of cognition that decline with older age, concerns with relying on physician self-reported competency, challenges with cognitive screening in older physicians, and a general data gap linking cognitive levels and fitness to practice.

Read News Item